Mupirocin Resistance Among Methicillin-resistant Staphylococcus Aureus-colonized Patients at Admission to a Tertiary Care Medical Center

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2009 May 29

PMID 19474267

Citations 12

Authors

Tara Babu

Violeta Rekasius

Jorge P Parada

Paul Schreckenberger

Malliswari Challapalli

Affiliations

Soon will be listed here.

Abstract

All patients admitted to our tertiary care hospital from 1 December 2007 to 10 June 2008 were screened for methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) nasal colonization, and the isolates were tested for mupirocin susceptibility by using Etest. Mupirocin resistance (MR) was noted to occur in 3.4% of MRSA carriers, and high-level MR was noted to occur in 0.62% of carriers.

Citing Articles

Phenotypic and genotypic characterization of strains isolated from otitis externa: Emergence of CC30- t019-SCC IV carrying PVL as major genotype.

Rahmani Z, Hosseini S, Bagheri P, Dadashi M, Haghighi M, Goudarzi M Heliyon. 2024; 10(11):e32002.

PMID: 38868027 PMC: 11168311. DOI: 10.1016/j.heliyon.2024.e32002.

Dissemination of Methicillin-Resistant Staphylococcus aureus Sequence Type 764 Isolates with Mupirocin Resistance in China.

Guo Y, Xu L, Wang B, Rao L, Xu Y, Wang X Microbiol Spectr. 2023; 11(1):e0379422.

PMID: 36622214 PMC: 9927232. DOI: 10.1128/spectrum.03794-22.

Ozenoxacin: A novel topical antibiotic.

Santhosh P, Thomas M Indian J Dermatol Venereol Leprol. 2021; 87(1):131-134.

PMID: 33580932 DOI: 10.25259/IJDVL_191_20.

New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics.

Principi N, Argentiero A, Neglia C, Gramegna A, Esposito S Pharmaceuticals (Basel). 2020; 13(11).

PMID: 33113966 PMC: 7690713. DOI: 10.3390/ph13110333.

2020 American Society for Microbiology Awards Program Honorees in Clinical Microbiology.

Munson E J Clin Microbiol. 2020; 58(5).

PMID: 31996438 PMC: 7180258. DOI: 10.1128/JCM.00082-20.

References

Annigeri R, Conly J, Vas S, Dedier H, Prakashan K, Bargman J . Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int. 2002; 21(6):554-9. View

Orrett F . The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report. Jpn J Infect Dis. 2008; 61(2):107-10. View

Casewell M, Hill R . Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent. J Antimicrob Chemother. 1987; 19(1):1-5. DOI: 10.1093/jac/19.1.1. View

Miller M, Dascal A, Portnoy J, Mendelson J . Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol. 1996; 17(12):811-3. DOI: 10.1086/647242. View

Fuchs P, Jones R, Barry A . Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol. 1990; 28(3):608-9. PMC: 269673. DOI: 10.1128/jcm.28.3.608-609.1990. View

Jones J, Rogers T, Brookmeyer P, Dunne Jr W, Storch G, Coopersmith C . Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis. 2007; 45(5):541-7. DOI: 10.1086/520663. View

Santos K, Teixeira L, Bravo Neto G, Fonseca L, Gontijo Filho P . Mupirocin- and methicillin-resistant Staphylococcus aureus spreading in an intermediate-care unit in a Brazilian hospital. Infect Control Hosp Epidemiol. 1998; 19(9):622-3. DOI: 10.1086/647886. View

Perez-Roth E, Lopez-Aguilar C, Alcoba-Florez J, Mendez-Alvarez S . High-level mupirocin resistance within methicillin-resistant Staphylococcus aureus pandemic lineages. Antimicrob Agents Chemother. 2006; 50(9):3207-11. PMC: 1563509. DOI: 10.1128/AAC.00059-06. View

Upton A, Lang S, Heffernan H . Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother. 2003; 51(3):613-7. DOI: 10.1093/jac/dkg127. View

10.

Robicsek A, Beaumont J, Paule S, Hacek D, Thomson Jr R, Kaul K . Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008; 148(6):409-18. DOI: 10.7326/0003-4819-148-6-200803180-00003. View

11.

Fridkin S, Hill H, Volkova N, Edwards J, Lawton R, Gaynes R . Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis. 2002; 8(7):697-701. PMC: 2730337. DOI: 10.3201/eid0807.010427. View

12.

Huang S, Platt R . Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis. 2003; 36(3):281-5. DOI: 10.1086/345955. View

13.

Capobianco J, Doran C, Goldman R . Mechanism of mupirocin transport into sensitive and resistant bacteria. Antimicrob Agents Chemother. 1989; 33(2):156-63. PMC: 171448. DOI: 10.1128/AAC.33.2.156. View

14.

Cookson B . The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother. 1998; 41(1):11-8. DOI: 10.1093/jac/41.1.11. View

15.

Nelson R . Benefits and drawbacks of universal surveillance of methicillin-resistant Staphylococcus aureus. Ann Intern Med. 2008; 149(1):67-8. DOI: 10.7326/0003-4819-149-1-200807010-00025. View

16.

Gilbart J, Perry C, Slocombe B . High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrob Agents Chemother. 1993; 37(1):32-8. PMC: 187600. DOI: 10.1128/AAC.37.1.32. View

17.

Semret M, Miller M . Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains. Infect Control Hosp Epidemiol. 2001; 22(9):578-80. DOI: 10.1086/501956. View

18.

Yoo J, Shin E, Cha J, Lee J, Jung Y, Lee K . Clonal dissemination and mupA gene polymorphism of mupirocin-resistant Staphylococcus aureus isolates from long-term-care facilities in South Korea. Antimicrob Agents Chemother. 2005; 50(1):365-7. PMC: 1346793. DOI: 10.1128/AAC.50.1.365-367.2006. View

19.

Kluytmans J, Mouton J, VandenBergh M, Manders M, Maat A, Wagenvoort J . Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol. 1996; 17(12):780-5. DOI: 10.1086/647236. View

20.

Klevens R, Edwards J, Tenover F, McDonald L, Horan T, Gaynes R . Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis. 2006; 42(3):389-91. DOI: 10.1086/499367. View